Venmax Drugs And Pharmaceuticals
VENMAX •BSE

Venmax Drugs And Pharmaceuticals

₹14.50-0.31 (2.09%)1D
1D
1W
1M
3M
6M
1Y
3Y
5Y
All
Create Stock SIPAutomate your investments in this
Overview
Technicals
News
Events

Performance

Today’s low
14.11
Today’s high
15.00
52 week low
12.71
52 week high
31.49
Open price
14.99
Previous close
14.81
Live volume
1,380
Lower circuit
11.60
Upper circuit
17.40

Fundamentals

Market Cap
₹21Cr
ROE
1.87%
P/E Ratio(TTM)
77.95
EPS(TTM)
0.19
P/B Ratio
1.03
Dividend Yield
0.00%
Industry P/E
51.55
Book Value
14.37
Debt to Equity
0.01
Face Value
10

Financial performance

Quarterly
Yearly
All Financials
JUN '26
₹2.48Cr
-38.46%
₹0.12Cr
+9.09%
014916
Jun '25
Sep '25
Dec '25
Mar '26
Jun '26
Revenue growthValue
1Y (TTM)+105%
3Y CAGR+169%
Profit growthValue
1Y (TTM)+200%
3Y CAGR+3%

About

Venmax is primarily engaged in the manufacturing and trading of pharmaceutical formulations, drug intermediates, and Active Pharmaceutical Ingredients (APIs). The company is currently developing oncology products and is in the planning stages of establishing a new manufacturing unit with a cGMP facility at the Hyderabad Pharma Cluster to target export markets.;
CEO/MD
Mr. Venkata Rao Sadhanala
Founded in
1988
BSE symbol
531015

Shareholding pattern

Jun '25
Sep '25
Dec '25
Mar '26
Jun '26
Shareholder details

Similar stocks

StockMkt price (1D)52 week performanceMarket capP/E ratioP/B ratio
₹2,631.90
-84.50 (3.11%)
L
    H
    20,008.9429.515.94
    PfizerPFIZER
    ₹3,858.90
    -16.40 (0.42%)
    L
      H
      17,635.9823.994.2
      Natco PharmaNATCOPHARM
      ₹821.30
      +0.55 (0.07%)
      L
        H
        16,120.1014.081.54
        ₹999.30
        -29.50 (2.87%)
        L
          H
          15,940.3545.362.25
          2026
          7
          Aug
          Quarterly Result
          Release date
          14
          May
          Quarterly & Annual Result
          Release date
          7
          Feb
          Quarterly Result
          Release date
          2025
          12
          Nov
          Quarterly Result
          Release date
          23
          Jul
          Quarterly Result
          Release date
          Events calendar
          View upcoming events in other stocks